News
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
Insmed's Brinsupri is the first DPP1 inhibitor approved by the FDA and the first treatment for bronchiectasis to reach the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback